Integrated Core Strategies (Us) Llc - Sep 30, 2025 SCHEDULE 13G/A Report for Nektar Therapeutics Common Stock, par value $0.0001 per share (NKTR)

Filing Manager
INTEGRATED CORE STRATEGIES (US) LLC
Reporting Manager
Millennium Management LLC
Security
Nektar Therapeutics Common Stock, par value $0.0001 per share
Symbol
NKTR
Shares outstanding
19M shares
Disclosed Ownership
571K shares
Ownership
3%
Form type
SCHEDULE 13G/A
Date filed
10/28/2025, 04:10 PM
Date of event
Sep 30, 2025
Previous filing
Jul 3, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Integrated Core Strategies (US) LLC 1.8% 334K 0 334K /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Management LLC 3% 571K 0 571K /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 3% 571K 0 571K /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 3% 571K 0 571K /s/ Israel A. Englander Israel A. Englander